What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Drug Discovery Clinical Trial Clinical Development

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1287681

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1287681

Diverticulitis Disease Market Share, Size, Trends, Industry Analysis Report, By Type (Uncomplicated, Complicated); By Treatment; By End-User; By Region; Segment Forecast, 2023-2032

PUBLISHED: April 1, 2023

PAGES: 115 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The global diverticulitis disease market size is expected to reach USD 3.86 billion by 2032, according to a new study by Polaris market research. The report "Diverticular Disease Market Share, Size, Trends, Industry Analysis Report, By Type (Uncomplicated, Complicated); By Treatment; By End-User; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rise in the elderly population causes a rise in the patient population, which in turn increases the market for diverticular illness. The worldwide market has therefore forecast the demand for medications for improved treatment. It has been primarily fueled by the rising demand for cutting-edge medical care, the rise in cigarette smoking, and the broad movement of young people toward sedentary lifestyles. For instance, West Virginia had the highest smoking rate in the United States in 2022, with a rate of 23.8%, according to the CDC's 2022 report. The leading cause of the preventable disease & recorded substantial deaths in the U.S alone, smoking accounts for almost 500,000 480,000 deaths annually. However, the CDC predicted that 30.8 million Americans or 12.5% of adults smoked cigarettes in 2020.

Diverticulosis and diverticular disease of the colon are becoming more common worldwide. Despite the fact that the majority of patients stay asymptomatic for a very long time, diverticular illness of the colon, particularly acute diverticulitis, is quite common and is beginning to put a large financial strain on national health systems. For instance, a research paper by Alexander T. Hawkins, published in 2022, states that diverticulosis of the sigmoid colon affects about 33% of people over the age of 60 and is frequent in the industrialized world. Diverticulitis could occur in up to 15% of these patients at some time in their lives.

The current emphasis is on determining the best therapy strategy through the testing of numerous treatments. Unfortunately, there is still a lack of solid data supporting the efficacy of a medicinal approach to preventing a recurrence of acute diverticulitis. Here, we give a succinct overview of these treatments' efficacy and prospects for the future.

Diverticular Disease Market Report Highlights

Uncomplicated will dominate the market in 2022, accounting for major sales. The primary reason for the market's expansion is the ongoing advancement in antibiotic treatment research.

In 2022, medications will rule the market. Since the primary element driving market growth is the use of antibiotics to treat infections that may arise in acute diverticulitis, the category benefits from this.

In 2022, hospitals made up the greatest revenue portion of the market. The key driver of market growth is the presence of experts in hospitals who can guide patients in selecting appropriate tests.

North America will produce majority of global income in 2022. Over the course of the forecast period, the market is predicted to gain from elements including the growing senior population and expanding public awareness of local health issues.

The global players with global presence include Sucampo Pharmaceuticals, Valeant Pharmaceuticals International, Synergy Pharmaceuticals, Ardelyx, Astellas Pharma, Novartis AG, Hikma Pharmaceuticals and Baxter International.

Polaris Market Research has segmented the Diverticular Disease Market report based on type, treatment, end-user and region:

Diverticular Disease, Type Outlook (Revenue - USD Billion, 2019 - 2032)

Uncomplicated
Complicated

Diverticular Disease, Treatment Outlook (Revenue - USD Billion, 2019 - 2032)

Medications
Surgery
Supportive care
Penicillin Antibiotic
Antibiotics
Dietary Supplements
IV fluids

Diverticular Disease, End-User Outlook (Revenue - USD Billion, 2019 - 2032)

Specialty centers
Hospitals
Research centers

Diverticular Disease, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa

Product Code: PM3168

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Diverticulitis Disease Market Insights

4.1. Diverticulitis Disease Market - End-User Snapshot
4.2. Diverticulitis Disease Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increased sedentary lifestyle adaptation and significant gastrointestinal growth
  - 4.2.1.2. Rising Demand for Oral Drugs
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Diverticulitis Disease Market End-User Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Diverticulitis Disease Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
5.3. Uncomplicated
- 5.3.1. Global Diverticulitis Disease Market, by Uncomplicated, by Region, 2019-2032 (USD Billion)
5.4. Complicated
- 5.4.1. Global Diverticulitis Disease Market, by Complicated, by Region, 2019-2032 (USD Billion)

6. Global Diverticulitis Disease Market, by Treatment

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
6.3. Medications
- 6.3.1. Global Diverticulitis Disease Market, by Medications, by Region, 2019-2032 (USD Billion)
6.4. Surgery
- 6.4.1. Global Diverticulitis Disease Market, by Surgery, by Region, 2019-2032 (USD Billion)
6.5. Supportive care
- 6.5.1. Global Diverticulitis Disease Market, by Supportive care, by Region, 2019-2032 (USD Billion)
6.6. Penicillin Antibiotic
- 6.6.1. Global Diverticulitis Disease Market, by Penicillin Antibiotic, by Region, 2019-2032 (USD Billion)
6.7. Antibiotics
- 6.7.1. Global Diverticulitis Disease Market, by Antibiotics, by Region, 2019-2032 (USD Billion)
6.8. Dietary Supplements
- 6.8.1. Global Diverticulitis Disease Market, by Dietary Supplements, by Region, 2019-2032 (USD Billion)
6.9. IV fluids
- 6.9.1. Global Diverticulitis Disease Market, by IV fluids, by Region, 2019-2032 (USD Billion)

7. Global Diverticulitis Disease Market, by End-User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
7.3. Specialty centres
- 7.3.1. Global Diverticulitis Disease Market, by Specialty centres, By Region, 2019-2032 (USD Billion)
7.4. Hospitals
- 7.4.1. Global Diverticulitis Disease Market, by Hospitals, By Region, 2019-2032 (USD Billion)
7.5. Research centres
- 7.5.1. Global Diverticulitis Disease Market, by Research centres, By Region, 2019-2032 (USD Billion)

8. Global Diverticulitis Disease Market, by Geography

8.1. Key findings
8.2. Introduction
- 8.2.1. Diverticulitis Disease Market Assessment, By Geography, 2019-2032 (USD Billion)
8.3. Diverticulitis Disease Market - North America
- 8.3.1. North America: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
- 8.3.2. North America: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
- 8.3.3. North America: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.3.4. Diverticulitis Disease Market - U.S.
  - 8.3.4.1. U.S.: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.3.4.2. U.S.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.3.4.3. U.S.: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.3.5. Diverticulitis Disease Market - Canada
  - 8.3.5.1. Canada: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.3.5.2. Canada.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.3.5.3. Canada: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
8.4. Diverticulitis Disease Market - Europe
- 8.4.1. Europe: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
- 8.4.3. Europe: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.4.4. Diverticulitis Disease Market - UK
  - 8.4.4.1. UK: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.4.4.2. UK.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.4.4.3. UK: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.4.5. Diverticulitis Disease Market - France
  - 8.4.5.1. France: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.4.5.2. France.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.4.5.3. France: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.4.6. Diverticulitis Disease Market - Germany
  - 8.4.6.1. Germany: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.4.6.2. Germany.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.4.6.3. Germany: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.4.7. Diverticulitis Disease Market - Italy
  - 8.4.7.1. Italy: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.4.7.2. Italy.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.4.7.3. Italy: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.4.8. Diverticulitis Disease Market - Spain
  - 8.4.8.1. Spain: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.4.8.2. Spain.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.4.8.3. Spain: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.4.9. Diverticulitis Disease Market - Netherlands
  - 8.4.9.1. Netherlands: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.4.9.2. Netherlands.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.4.9.3. Netherlands: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.4.10. Diverticulitis Disease Market - Russia
  - 8.4.10.1. Russia: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.4.10.2. Russia.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.4.10.3. Russia: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
8.5. Diverticulitis Disease Market - Asia Pacific
- 8.5.1. Asia Pacific: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.5.4. Diverticulitis Disease Market - China
  - 8.5.4.1. China: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.5.4.2. China.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.5.4.3. China: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.5.5. Diverticulitis Disease Market - India
  - 8.5.5.1. India: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.5.5.2. India.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.5.5.3. India: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.5.6. Diverticulitis Disease Market - Malaysia
  - 8.5.6.1. Malaysia: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.5.6.2. Malaysia.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.5.6.3. Malaysia: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.5.7. Diverticulitis Disease Market - Japan
  - 8.5.7.1. Japan: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.5.7.2. Japan.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.5.7.3. Japan: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.5.8. Diverticulitis Disease Market - Indonesia
  - 8.5.8.1. Indonesia: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.5.8.2. Indonesia.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.5.8.3. Indonesia: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.5.9. Diverticulitis Disease Market - South Korea
  - 8.5.9.1. South Korea: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.5.9.2. South Korea.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.5.9.3. South Korea: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
8.6. Diverticulitis Disease Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.6.4. Diverticulitis Disease Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.6.4.2. Saudi Arabia.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.6.5. Diverticulitis Disease Market - UAE
  - 8.6.5.1. UAE: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.6.5.2. UAE.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.6.5.3. UAE: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.6.6. Diverticulitis Disease Market - Israel
  - 8.6.6.1. Israel: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.6.6.2. Israel.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.6.6.3. Israel: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.6.7. Diverticulitis Disease Market - South Africa
  - 8.6.7.1. South Africa: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.6.7.2. South Africa.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.6.7.3. South Africa: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
8.7. Diverticulitis Disease Market - Latin America
- 8.7.1. Latin America: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.7.4. Diverticulitis Disease Market - Mexico
  - 8.7.4.1. Mexico: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.7.4.2. Mexico.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.7.4.3. Mexico: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.7.5. Diverticulitis Disease Market - Brazil
  - 8.7.5.1. Brazil: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.7.5.2. Brazil.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.7.5.3. Brazil: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
- 8.7.6. Diverticulitis Disease Market - Argentina
  - 8.7.6.1. Argentina: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
  - 8.7.6.2. Argentina.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
  - 8.7.6.3. Argentina: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Pfizer
- 10.1.1. Company Overview
- 10.1.2. Financial PerTreatmentance
- 10.1.3. Treatment Benchmarking
- 10.1.4. Recent Development
10.2. G.D. Searle
- 10.2.1. Company Overview
- 10.2.2. Financial PerTreatmentance
- 10.2.3. Treatment Benchmarking
- 10.2.4. Recent Development
10.3. Teva Pharmaceutical
- 10.3.1. Company Overview
- 10.3.2. Financial PerTreatmentance
- 10.3.3. Treatment Benchmarking
- 10.3.4. Recent Development
10.4. Abbott Laboratories
- 10.4.1. Company Overview
- 10.4.2. Financial PerTreatmentance
- 10.4.3. Treatment Benchmarking
- 10.4.4. Recent Development
10.5. Braun Medical
- 10.5.1. Company Overview
- 10.5.2. Financial PerTreatmentance
- 10.5.3. Treatment Benchmarking
- 10.5.4. Recent Development
10.6. GSK
- 10.6.1. Company Overview
- 10.6.2. Financial PerTreatmentance
- 10.6.3. Treatment Benchmarking
- 10.6.4. Recent Development
10.7. Bayer HealthCare
- 10.7.1. Company Overview
- 10.7.2. Financial PerTreatmentance
- 10.7.3. Treatment Benchmarking
- 10.7.4. Recent Development
10.8. Roche Holding
- 10.8.1. Company Overview
- 10.8.2. Financial PerTreatmentance
- 10.8.3. Treatment Benchmarking
- 10.8.4. Recent Development
10.9. Johnson and Johnson
- 10.9.1. Company Overview
- 10.9.2. Financial PerTreatmentance
- 10.9.3. Treatment Benchmarking
- 10.9.4. Recent Development
10.10. Sucampo Pharmaceuticals
- 10.10.1. Company Overview
- 10.10.2. Financial PerTreatmentance
- 10.10.3. Treatment Benchmarking
- 10.10.4. Recent Development
10.11. Valeant Pharmaceuticals
- 10.11.1. Company Overview
- 10.11.2. Financial PerTreatmentance
- 10.11.3. Treatment Benchmarking
- 10.11.4. Recent Development
10.12. Synergy Pharmaceuticals
- 10.12.1. Company Overview
- 10.12.2. Financial PerTreatmentance
- 10.12.3. Treatment Benchmarking
- 10.12.4. Recent Development
10.13. Ardelyx
- 10.13.1. Company Overview
- 10.13.2. Financial PerTreatmentance
- 10.13.3. Treatment Benchmarking
- 10.13.4. Recent Development
10.14. Astellas Pharma
- 10.14.1. Company Overview
- 10.14.2. Financial PerTreatmentance
- 10.14.3. Treatment Benchmarking
- 10.14.4. Recent Development
10.15. Novartis
- 10.15.1. Company Overview
- 10.15.2. Financial PerTreatmentance
- 10.15.3. Treatment Benchmarking
- 10.15.4. Recent Development
10.16. Hikma Pharmaceuticals
- 10.16.1. Company Overview
- 10.16.2. Financial PerTreatmentance
- 10.16.3. Treatment Benchmarking
- 10.16.4. Recent Development
10.17. Baxter International
- 10.17.1. Company Overview
- 10.17.2. Financial PerTreatmentance
- 10.17.3. Treatment Benchmarking
- 10.17.4. Recent Development

Product Code: PM3168

List of Tables

Table 1 Global Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 2 Global Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 3 Global Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 4 Diverticulitis Disease Market Assessment, By Geography, 2019-2032 (USD Billion)
Table 5 North America: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 6 North America: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 7 North America: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 8 U.S.: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 9 U.S.: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 10 U.S.: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 11 Canada: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 12 Canada: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 13 Canada: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 14 Europe: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 15 Europe: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 16 Europe: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 17 UK: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 18 UK: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 19 UK: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 20 France: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 21 France: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 22 France: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 23 Germany: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 24 Germany: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 25 Germany: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 26 Italy: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 27 Italy: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 28 Italy: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 29 Spain: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 30 Spain: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 31 Spain: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 32 Netherlands: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 33 Netherlands: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 34 Netherlands: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 35 Russia: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 36 Russia: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 37 Russia: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 38 Asia Pacific: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 39 Asia Pacific: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 40 Asia Pacific: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 41 China: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 42 China: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 43 China: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 44 India: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 45 India: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 46 India: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 47 Malaysia: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 48 Malaysia: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 49 Malaysia: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 50 Japan: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 51 Japan: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 52 Japan: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 53 Indonesia: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 54 Indonesia: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 55 Indonesia: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 56 South Korea: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 57 South Korea: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 58 South Korea: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 59 Middle East & Africa: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 60 Middle East & Africa: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 61 Middle East & Africa: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 62 Saudi Arabia: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 63 Saudi Arabia: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 64 Saudi Arabia: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 65 UAE: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 66 UAE: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 67 UAE: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 68 Israel: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 69 Israel: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 70 Israel: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 71 South Africa: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 72 South Africa: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 73 South Africa: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 74 Latin America: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 75 Latin America: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 76 Latin America: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 77 Mexico: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 78 Mexico: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 79 Mexico: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 80 Brazil: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 81 Brazil: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 82 Brazil: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)
Table 83 Argentina: Diverticulitis Disease Market, by Type, 2019-2032 (USD Billion)
Table 84 Argentina: Diverticulitis Disease Market, by Treatment, 2019-2032 (USD Billion)
Table 85 Argentina: Diverticulitis Disease Market, by End-User, 2019-2032 (USD Billion)

List of Figures

Figure 1. Global Diverticulitis Disease Market, 2019-2032 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Treatment
Figure 7. Global Diverticulitis Disease Market, by Treatment, 2021 & 2030 (USD Billion)
Figure 8. Market by Type
Figure 9. Global Diverticulitis Disease Market, by Type, 2021 & 2030 (USD Billion)
Figure 10. Market by End-User
Figure 11. Global Diverticulitis Disease Market, by End-User, 2021 & 2030 (USD Billion)
Figure 12. Diverticulitis Disease Market Assessment, By Geography, 2019-2032 (USD Billion)
Figure 13. Strategic Analysis - Diverticulitis Disease Market